Risk-based thinking: Why does risk impact how medicines are supplied?
The ethos that high-risk activities should elicit the most significant mitigation effort, and low-risk, lower effort has been a mainstay of the global regulatory approach to risk management of therapeutic products for many years. In 2006, ICH Q9 Quality Risk Management was published and included the statement: The level of effort, formality and documentation of…

